BHST logo

BioHarvest Sciences Inc. Stock Price

NasdaqGM:BHST Community·US$149.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

BHST Share Price Performance

US$6.31
-0.14 (-2.17%)
US$6.31
-0.14 (-2.17%)
Price US$6.31

BHST Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with excellent balance sheet.

2 Risks
3 Rewards

BioHarvest Sciences Inc. Key Details

US$32.7m

Revenue

US$13.3m

Cost of Revenue

US$19.4m

Gross Profit

US$31.3m

Other Expenses

-US$11.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.52
59.21%
-36.33%
78.1%
View Full Analysis

About BHST

Founded
n/a
Employees
n/a
CEO
Ilan Sobel
WebsiteView website
www.bioharvest.com

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.

Recent BHST News & Updates

Recent updates

No updates